Brief: Chr. Hansen Q4 Adjusted EBIT EUR 99 Million Vs. Estimate EUR 99 Million
12/10/2023 07:02
Oct 12 (Reuters) - Chr. Hansen Q4 revenue EUR 352 million vs. estimate EUR 350 million. * Q4 adjusted EBIT margin 28% vs. estimate 28.3% * Q4 organic growth 11% vs. estimate 10.4% * outlook FY adjusted EBIT margin 26-27% * outlook FY organic growth 11%
Recent news on Chr Hansen Holding A/S
See all newsJefferies sees above peer growth for Novozymes, ups to 'buy'
Brief: Combination Of Novozymes, Chr. Hansen Is Completed
Brief: Novozymes Says All Necessary Regulatory Approvals Obtained For Combination Novozymes And Chr. Hansen
European Commission clears Novozymes, Chr. Hansen merger (updated)
European Commission clears Novozymes, Chr. Hansen merger